Selected publications Circulating tumor cell number as a response measure of prolonged survival for metastatic castration-resistant prostate cancer: A comparison with prostate-specific antigen across five randomized phase III clinical trials. Journal of Clinical Oncology. 2018 Academic Article GET IT Times cited: 40
